AR010584A1 - Compuestos derivados de 1,2 dihidroxietilpiridina y procesos para prepararlos, intermedios y procesos para preparar estos ultimos - Google Patents

Compuestos derivados de 1,2 dihidroxietilpiridina y procesos para prepararlos, intermedios y procesos para preparar estos ultimos

Info

Publication number
AR010584A1
AR010584A1 ARP970105279A ARP970105279A AR010584A1 AR 010584 A1 AR010584 A1 AR 010584A1 AR P970105279 A ARP970105279 A AR P970105279A AR P970105279 A ARP970105279 A AR P970105279A AR 010584 A1 AR010584 A1 AR 010584A1
Authority
AR
Argentina
Prior art keywords
formula
processes
prepare
compounds
substituents
Prior art date
Application number
ARP970105279A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of AR010584A1 publication Critical patent/AR010584A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
ARP970105279A 1996-11-14 1997-11-12 Compuestos derivados de 1,2 dihidroxietilpiridina y procesos para prepararlos, intermedios y procesos para preparar estos ultimos AR010584A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3088096P 1996-11-14 1996-11-14

Publications (1)

Publication Number Publication Date
AR010584A1 true AR010584A1 (es) 2000-06-28

Family

ID=21856496

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105279A AR010584A1 (es) 1996-11-14 1997-11-12 Compuestos derivados de 1,2 dihidroxietilpiridina y procesos para prepararlos, intermedios y procesos para preparar estos ultimos

Country Status (32)

Country Link
US (1) US6291489B1 (US06291489-20010918-C00047.png)
EP (1) EP0938476B1 (US06291489-20010918-C00047.png)
JP (1) JP3510635B2 (US06291489-20010918-C00047.png)
KR (1) KR20000053314A (US06291489-20010918-C00047.png)
CN (1) CN1237160A (US06291489-20010918-C00047.png)
AP (1) AP805A (US06291489-20010918-C00047.png)
AR (1) AR010584A1 (US06291489-20010918-C00047.png)
AT (1) ATE319687T1 (US06291489-20010918-C00047.png)
AU (1) AU4634697A (US06291489-20010918-C00047.png)
BG (1) BG103393A (US06291489-20010918-C00047.png)
BR (1) BR9712951A (US06291489-20010918-C00047.png)
CA (1) CA2270386C (US06291489-20010918-C00047.png)
CO (1) CO4930261A1 (US06291489-20010918-C00047.png)
DE (1) DE69735433D1 (US06291489-20010918-C00047.png)
EA (1) EA199900375A1 (US06291489-20010918-C00047.png)
GT (1) GT199700118A (US06291489-20010918-C00047.png)
HR (1) HRP970612A2 (US06291489-20010918-C00047.png)
ID (1) ID18898A (US06291489-20010918-C00047.png)
IL (1) IL129688A0 (US06291489-20010918-C00047.png)
IS (1) IS5029A (US06291489-20010918-C00047.png)
MA (1) MA24401A1 (US06291489-20010918-C00047.png)
MY (1) MY132507A (US06291489-20010918-C00047.png)
NO (1) NO992296L (US06291489-20010918-C00047.png)
OA (1) OA11044A (US06291489-20010918-C00047.png)
PA (1) PA8441401A1 (US06291489-20010918-C00047.png)
PE (1) PE10299A1 (US06291489-20010918-C00047.png)
TN (1) TNSN97172A1 (US06291489-20010918-C00047.png)
TR (1) TR199901063T2 (US06291489-20010918-C00047.png)
UY (1) UY24774A1 (US06291489-20010918-C00047.png)
WO (1) WO1998021184A1 (US06291489-20010918-C00047.png)
YU (1) YU22099A (US06291489-20010918-C00047.png)
ZA (1) ZA9710186B (US06291489-20010918-C00047.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010042518A (ko) * 1998-04-08 2001-05-25 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 신규 제초제
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
KR20010102198A (ko) * 1999-02-16 2001-11-15 후루타 타케시 치환 아세틸피리딘 유도체 및 그를 이용하는 광학활성 β3작용제 중간체의 제조 방법
US6455734B1 (en) 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
ATE280167T1 (de) * 1999-07-23 2004-11-15 Pfizer Prod Inc Zwischenprodukte und ein verfahren zur herstellung von beta3-adrenergischer rezeptor- agoniste
US20040265991A1 (en) * 2001-10-17 2004-12-30 Naoaki Taoka Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
BR0307996A (pt) 2002-02-27 2004-12-07 Pfizer Prod Inc Processos e intermediários úteis na preparação de receptores de agonistas beta3-adrenérgicos
WO2003072573A1 (en) * 2002-02-27 2003-09-04 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
AU2004235923B2 (en) 2003-05-09 2008-01-24 F. Hoffmann-La Roche Ag Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
MX2010012814A (es) 2008-05-23 2010-12-20 Amira Pharmaceuticals Inc Inhibidor de proteina activadora de 5-lipoxigenasa.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
NZ265692A (en) 1993-06-14 1997-02-24 Pfizer Indole- and benzofuran- containing hydroxyamines and analogs; pharmaceutical compositions
IL113410A (en) * 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
JPH11504648A (ja) * 1995-05-10 1999-04-27 ファイザー・インコーポレーテッド β−アドレナリン作動性アゴニスト
MX9708621A (es) 1995-05-10 1998-02-28 Pfizer AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.

Also Published As

Publication number Publication date
JP2000504347A (ja) 2000-04-11
NO992296D0 (no) 1999-05-12
TR199901063T2 (xx) 1999-08-23
BR9712951A (pt) 1999-12-07
IS5029A (is) 1999-04-16
EP0938476B1 (en) 2006-03-08
MA24401A1 (fr) 1998-07-01
HRP970612A2 (en) 1998-08-31
WO1998021184A1 (en) 1998-05-22
CN1237160A (zh) 1999-12-01
UY24774A1 (es) 1998-05-05
CA2270386A1 (en) 1998-05-22
PE10299A1 (es) 1999-02-10
ID18898A (id) 1998-05-20
GT199700118A (es) 1999-05-05
ATE319687T1 (de) 2006-03-15
CA2270386C (en) 2004-08-03
TNSN97172A1 (fr) 2005-03-15
EA199900375A1 (ru) 1999-12-29
JP3510635B2 (ja) 2004-03-29
PA8441401A1 (es) 2000-05-24
CO4930261A1 (es) 2000-06-27
AP9701147A0 (en) 1998-01-31
KR20000053314A (ko) 2000-08-25
AP805A (en) 2000-01-28
OA11044A (en) 2002-02-20
DE69735433D1 (de) 2006-05-04
IL129688A0 (en) 2000-02-29
US6291489B1 (en) 2001-09-18
AU4634697A (en) 1998-06-03
BG103393A (en) 2000-07-31
EP0938476A1 (en) 1999-09-01
ZA9710186B (en) 1999-05-12
YU22099A (sh) 2001-09-28
NO992296L (no) 1999-05-12
MY132507A (en) 2007-10-31

Similar Documents

Publication Publication Date Title
AR010584A1 (es) Compuestos derivados de 1,2 dihidroxietilpiridina y procesos para prepararlos, intermedios y procesos para preparar estos ultimos
PE20051039A1 (es) [1,8] naftiridin-2-onas y compuestos relacionados
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
PE20040164A1 (es) Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas
DOP2005000071A (es) "compuestos de metil-aril o heteroaril-amida sustituida"
PE58599A1 (es) 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas
PE20050702A1 (es) Uso de derivados de n-aril hidracina para combatir pestes
AR035756A1 (es) Uso de carbamatos en la preparacion de medicamentos para la prevencion o tratamiento de trastornos neurodegenerativos
ES2038202T3 (es) Derivados de alcanos trifluorometil insecticidos.
AR033426A1 (es) Uso de compuestos carbamatos en la prevencion o el tratamiento de trastornos de movimiento
ES2103801T3 (es) Acidos amicos n,n-disustituidos y sus sales de amonio asi como la utilizacion de estos como agentes emulsionantes.
ES2061714T3 (es) Grupos de anclaje inestables frente a acidos para la sintesis de amidas peptidicas mediante el metodo en fase solida.
AR005532A1 (es) Compuestos de dihalopropeno, las composiciones insecticidas/acaricidas que los contienen y los intermediarios de sintesis de dichos compuestos
BR0207830A (pt) Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade
MXPA03000619A (es) Compuestos de carbamato para utilizarlos en la prevencion o el tratamiento del dolor y la cefalea neuropaticos y el dolor asociado con la migrana.
BR0207829A (pt) Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos
AR004015A1 (es) Procedimiento para preparar compuestos de quinolina o sales farmaceuticamente aceptables de los mismos, y compuestos intermediarios
BR0116750A (pt) Método e composições para atrair mosquitos
AR031720A1 (es) Benzimidazoles n-alcoxialquil sustituidos, proceso para su preparacion, composiciones, y uso de estos compuestos para preparar composiciones antiparasitarias
DK1990343T3 (da) Azaindoler
ES2163162T3 (es) Procedimiento para el revestimiento de substratos electroconductivos.
RU2004100966A (ru) Карбаматные соединения для применения для предотвращения или лечения невроматической боли и боли, связанной с кластерной и мигреневой головной болью
CY1106038T1 (el) Καρβαμικες ενωσεις για χρηση στην προληψη ή την αγωγη του νeυpοπαθους πονου και του πονου που συνδεεται με την ισταμινογενη κεφαλαλγια και την ημικρανια
PE20040711A1 (es) Compuestos de haloalqueno, proceso para su produccion y pesticidas que los contienen
ECSP972312A (es) Procedimiento para piridinas sustituidas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal